Feasibility Study of Mesoporous Silica Particles for Pulmonary Drug Delivery: Therapeutic Treatment with Dexamethasone in a Mouse Model of Airway Inflammation
- Supplementary File 1:
PDF-Document (PDF, 1007 KiB)
Gulin-Sarfraz, T.; Jonasson, S.; Wigenstam, E.; von Haartman, E.; Bucht, A.; Rosenholm, J.M. Feasibility Study of Mesoporous Silica Particles for Pulmonary Drug Delivery: Therapeutic Treatment with Dexamethasone in a Mouse Model of Airway Inflammation. Pharmaceutics 2019, 11, 149. https://doi.org/10.3390/pharmaceutics11040149
Gulin-Sarfraz T, Jonasson S, Wigenstam E, von Haartman E, Bucht A, Rosenholm JM. Feasibility Study of Mesoporous Silica Particles for Pulmonary Drug Delivery: Therapeutic Treatment with Dexamethasone in a Mouse Model of Airway Inflammation. Pharmaceutics. 2019; 11(4):149. https://doi.org/10.3390/pharmaceutics11040149
Chicago/Turabian StyleGulin-Sarfraz, Tina, Sofia Jonasson, Elisabeth Wigenstam, Eva von Haartman, Anders Bucht, and Jessica M. Rosenholm. 2019. "Feasibility Study of Mesoporous Silica Particles for Pulmonary Drug Delivery: Therapeutic Treatment with Dexamethasone in a Mouse Model of Airway Inflammation" Pharmaceutics 11, no. 4: 149. https://doi.org/10.3390/pharmaceutics11040149